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could be observed after every DFPP therapies and negative-
detected at exit of separator. No adverse events were
observed in all patients.
Conclusion: DFPP plus antivirus drug therapy is safe and
effective treatment for genotype 1b HCV patients with high
HCVRNA load.
Figure: Comparison of HCVRNA load degression. Patient 1
received DFPP plus IFN and ribavirin combination therapy.
HCV RNA (IU/ml) changings before and after every times of DFPP
(HCV RNA were <1000 IU/ml at 13th days after the 5th DFPP)
Time of DFPP HCV RNA
before DFPP afterDFPP intramembrane extramembrane
1st 3.47E+07 2.27E+07 2.68E+07 <e3
2nd 1.99E+06 1.57E+06 2.55E+06 <e3
3rd 2.48E+05 1.39E+05 3.12E+05 <e3
4th 4.42E+04 3.96E+04 2.56E+04 <e3
5th 2.21E+05 1.94E+05 2.45E+05 <e3
PP-137 Isolation of Ag_AB complex for detection of HCV
Core antigen using ELISA method
S. Nourollahi1 *, M. Boutorabi2, A. Mirjalili3, M. Razaghi2,
M. Hashemi4. 1Zanjan Azad University, 2Pishtaz Teb
Company, 3Razi Vaccine and Serum Research Institute,
4Payamenour University of Tehran, Iran
Studies show that during ﬁrst days of infection with hepatitis
type C virus, core antigen will appear more quickly than
antibody against the virus. Therefore detecting core antigen
is a useful index for diagnosing infection.
In order to exclude the probable effect of antibody presence
against the Core antigen, the positive antibody serum
samples were treated by different solutions, including 1.5M
glycine buffer with pH = 2, 0.5 Normal chloridic acid, and
triton X-100 with 0.1% concentration.
Titration of antibodies present in the serums which were
treated by acid had shown a considerable decrease.
Nonetheless, no such titration decrease was observed
in samples treated to triton X-100. Antibody titration
had a substantial decrease after adjacency treatment to
with acidic solutions in samples with negative antigen
and positive PCR results with veriﬁed antibody presence.
Regarding the comparison of light absorbance of samples
with positive PCR and negative antigen results, adjacency
to glycine buffer (pH = 2) for one hour in 37oC resulted in
more increase in light absorbance than treatment with
normal chloridric acid in 37oC. One the other hand,
this indicates that increase in light absorbance in the
samples with positive antibody after adjacency treatment
with acidic solution for testing the antigen is a speciﬁc
phenomenon caused by separation of antibody from antigen
and subsequent identiﬁcation of Core antigen via this
evaluation technique.
Sensitivity of the test before and after adjacency treatment
of serum with 1.5M glycine solution was 57.3 and
88 percent, respectively, which indicates its favorite
sensitivity and speciﬁcity among studies so far.
The increase in test sensitivity subsequent to adjacency
to 1.5M glycine buffer indicates the elimination of
interference of antibodies presence against Core antigen
in serum.
PP-138 Correlations of plasma lipid level with serum
hepatitis C virus RNA and liver histopathological
steatosis in patients with chronic hepatitis C
Y.-R. Li1 *, W. Ling1, F.-X. Chen1, X.-L. Fan1. 1Beijing Ditan
Hospital, Beijing, China
Objectives: To investigate the relationship among plasma
lipid level, serum hepatitis C virus RNA load, and liver
histological steatosis in patients with chronic hepatitis C.
Methods: Fluorescent quantitative polymerase chain
reaction was used to detect the load of serum HCVRNA in 75
patients with chronic hepatitis C; The levels of plasma TG,
CHO, LDL, HDL, ApoA, ApoB were measured by biochemical
instrument. Liver biopsy was performed in 62 of 75 patients,
and histopathological changes were observed by HE staining
under light microscope and scored according to the grades
of liver necro-inﬂammatory activity, stages of liver ﬁbrosis
and liver steatosis.
Results: There were differences signiﬁcantly in the
levels of LDL, ApoB among the three groups (HCVRNA
<105copies/ml; 105 107 copies/ml; and >107copies/ml).
There were differences signiﬁcantly in HCVRNA load among
three groups depending on different liver steatosis. The
load of HCVRNA was positively correlated with that of LDL,
ApoB (r = 0.305, 0.417; P= 0.011, 0.001). 67.7% of CHC
patients had liver steatosis.
Conclusion: The levels of plasma LDL and ApoB were related
to the load of HCV rather than the degrees of liver injury
and ﬁbrosis.
PP-139 Efﬁcacy of treatment with interferon
alfa/ribavirin of patients with chronic viral
hepatitis C in relation to GNB3 polymorphism
L. Ziyakhanova1 *, E. Musabaev1, M. Abdukadirova1,
A. Khikmatullaeva1. 1Institute of Virology, Tashkent,
Uzbekistan
The insufﬁcient efﬁcacy of ethiotropic therapy in some
patients constantly interest of specialists for research of
the causes of different virological response to treatment of
the patients infected with HCV virus. In spite of this fact
that therapeutic response in patients with HCV is rather
dependent on virus genotype there are human genetic
factors giving therapeutic effect in patients infected with
genotype 1 HCV.
According to the data of some investigations (Sarrazin Ch
et al., 2005 and others) polymorphisms of some genes are
genetic markers of T-cellular immune response and induce
reduction of functional ability of immune cells in response
to some chemokines that indicates about possible link of the
response to antiviral therapy viral hepatitis C with genotype
of some genes. The blood samples for determination of
genotypes of viral hepatitis C and selection of the samples
for determination of C825T gene GNB3 were obtained from
60 patients with viral hepatitis C. The investigation includes
40 HCV positive patients with chronic hepatitis C who
received treatment with pegilated interferon alpha-2a in
combination with ribavirin during more than 24 weeks
and 20 patients without antiviral therapy. Control group
comprised of blood samples from 20 healthy subjects.
Diagnosis was based on the clinical picture of disease
during not less than 6 months of observation, increased
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of transaminases in blood serum and presence of anti HCV
and HCVRNA in the blood.
The positive response to alpha-2a interferon therapy was
found in 20 patients. Of them GNB3 gene was determined
in 3 (15%) patients. In the patients resistant to therapy or
with disease recurrence after antiviral therapy GNB3 C825T
allele was revealed in 12 (60%) patients.
According to our investigations we found increase in number
of GNB3 C825T carriers among the patients without response
to the antiviral treatment.
PP-140 Frequency of hepatitis C virus infection
in Pakistani patients with type 2
diabetes mellitus
N. Jadoon1 *, A. Shahzad1, R. Yaqoob1. 1Nishtar Medical
College Hospital, Multan, Pakistan
Background: There is an increasing evidence of a possible
epidemiological link between HCV infection and diabetes.
It is not known whether such a relationship exists in
patients here as well. We, therefore, investigated the
prevalence of HCV infection in diabetic patients in order to
elucidate the presence of a possible association between
the two endemics in this region. We wanted to compare
the prevalence of HCV infection in diabetic patients with a
sample form general population.
Methods: This cross-sectional study was carried out on 550
diabetes patients seen at diabetes clinic at Nishtar Hospital,
Multan during winter 2008. Patients’ diabetic status and HCV
antibody presence were noted. The control group comprised
of 550 volunteer blood donors attending the blood bank of
Nishtar Hospital, Multan during the period of study. Informed
consent was taken before taking the data. Data Analysis was
done using SPSS v16.
Results: The mean age of patients was 47.58 years while
the mean duration of diabetes was 7.02 years. The patients
were predominantly female (55.27%). Out of 550 patients
whose data was gathered, 86 patients were tested positive
for HCV antibody presence as compared to control in whom
45 people were infected with hepatitis C virus infection out
of 550 (OR = 4.60, 95%CI = 3.22 6.57, p < 0.01). No signiﬁcant
association was found between the duration of diabetes and
presence of HCV infection.
Conclusion: Hepatitis C virus infection is highly prevalent
among type 2 diabetic patients as compared to the control
group in this region. The nature of association and the
effects of other confounding factors need to be seen. It
remains to be elucidated how this co morbidity effects
progression of liver disease and diabetes.
PP-141 Prevalence of gallstones among persons with
chronic liver disease in Pakistan
A. Baig1 *, S. Memon1. 1Isra University Hospital, Pakistan
Background: We determined the association between
Chronic liver disease and Gallstones in a representative
sample of adults in Pakistan.
Methods: We included all the consecutive adults with
HCV antibody positive and HBsAg positive, who visited our
hepatology clinic from Jan 2009 to March 2009. We noted
the status and duration of disease, weight, BMI, associated
DM (Diabetes Mellitus), smoking, ethnicity and number of
children in case of women.
Result: There were 344 participants, out of them 289
(84%) were HCV antibody positive and 55 (16%) were HBsAg
positive. Overall prevalence of gallstones was 14.8%. 84.3%
of gallstones were among HCV antibody positive and 15.7%
among HBsAg positive individuals. Gallstones prevalence
increased with age with a predominance in patients of
more than 40 years of age (P value = 0.003). The frequency
of gallstones increased with the duration of liver disease
(P value = 0.05), peak was seen in patients who had chronic
liver disease for 2 4 years.
Conclusion: Chronic liver disease was strongly associated
with gallstones among men but not in women in our study
in Pakistan and gallstone was more common in adults with
increasing age and severity of liver disease.
PP-142 Clinical relevance of serum HCV core antigen
level and antiviral therapy response
Y.-Z. Zhang1 *, W.-J. Wu1, H. Jin1, Y.-Y. Liu1, Y.-W. Hu1,
Y.-X. Zhang1. 1Shanghai Public Health Clinical Center
Afﬁliated to Fudan University, China
Aim: To evaluate the signiﬁcance of HCV core antigen
detection in the determination of the efﬁcacy of HCV
antiviral therapy in China.
Methods: HCV core antigen was measured in sera of 35
chronic hepatitis C patients. Concentrations of HCV core
antigen and HCVRNA were analyzed at 4 time points before,
during and after the end of antiviral therapy.
Results: This study showed that the HCV core antigen
and HCVRNA concentrations in 35 HCV patients were
signiﬁcantly related. Decrease of HCV core antigen and
HCVRNA concentrations at 4th wk, 24th wk, 48th wk
were observed during antiviral therapy. HCV core antigen
at week 24 of therapy was signiﬁcantly lower than at
week 4 (P= 0.000). In contrast, no decrease was observed in
HCVRNA concentrations in the same time (P= 0.303). HCV
core antigen testing may be advantageous in some cases,
especially the negativity of HCV core antigen at week 4 for
prediction of non-response is reliable.
Conclusion: HCV core antigen represents a stable and
sensitive marker of viral replication, can be used to monitor
the clinical efﬁcacy of HCV antiviral therapy.
Author contribution: Wen-Juan Wu and Yun-Zhi Zhang
contributed equally to this work.
PP-143 Introduction of HCV quantiﬁcation as a
diagnostic tool in Mongolia: its signiﬁcance and
lessons learned
S. Batmunkh1 *, L. Nemekhbaatar2, A. Jazag1,
C. Jigjidsuren3, B. Oidov1, S. Byambaa1, T. Tseveg2,
T.-O. Bira1,4. 1Mongolian Association for the Study of Liver
Diseases (MASLD), Ulaanbaatar, Mongolia, 2Health Sciences
University of Mongolia, Ulaanbaatar, Mongolia, 3National
Cancer Center of Mongolia, Ulaanbaatar, Mongolia,
4National Center of Communicable Diseases of Mongolia,
Ulaanbaatar, Mongolia
Background: 17% of Mongolian population is infected with
HCV, which makes the country one of the top HCV infected
countries in the world. Though HCV quantiﬁcation method
was developed almost a decade ago it was only in 2009,
when it was ﬁrst introduced in Mongolia.
Method: Total of HCV 212 patients were enrolled in the
study, all of whom had HCV quantiﬁcation at Happy Veritas
clinical laboratory. HCV quantiﬁcation (Taqman real-time
PCR method) was performed by ABI7000. Applied Bio-
systems, USA. Commercially available HCV quantiﬁcation
kit was used in the study. Anti-HCV was purchased from
ACON laboratories, USA.
Result: Out of 212 patients who had HCV quantiﬁed only
35 were also checked for HCV antibody. Patients were
divided in high viral load >2 million HCV copies/ml, and
low-intermediate <2 million HCV copies/ml. we checked for
liver function tests in both groups. Only 3.1% of patients
in the high group had normal liver enzymes (AST< 30 IU),
while 47% had normal liver enzymes in low-intermediate
group. Average ALT 45 IU in low-intermediate group. Mean
